Lensar and Alcon Agree to Terminate Merger

Dow Jones03-17

By Kelly Cloonan

 

Lensar and Alcon agreed to terminate their merger agreement, citing expectations for pushback from the Federal Trade Commission.

Lensar, a medical technology company, said Monday the companies ended their agreement because they didn't expect to receive the necessary U.S. regulatory approvals in time to close the deal. The merger agreement had an outside date of April 23 and would have had a potential extended outside date of July 23.

Lensar Chief Executive Nick Curtis said the company is disappointed with the outcome and the FTC's intention to challenge the deal.

Lensar said it will retain the $10 million deposit contemplated by the merger agreement.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

March 16, 2026 17:22 ET (21:22 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment